Vaborbactam increases meropenem susceptibility in


Journal

mSphere
ISSN: 2379-5042
Titre abrégé: mSphere
Pays: United States
ID NLM: 101674533

Informations de publication

Date de publication:
24 10 2023
Historique:
medline: 27 10 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: ppublish

Résumé

To evaluate the resistance mechanisms among

Identifiants

pubmed: 37768064
doi: 10.1128/msphere.00162-23
pmc: PMC10597463
doi:

Substances chimiques

Meropenem FV9J3JU8B1
Anti-Bacterial Agents 0
vaborbactam 1C75676F8V
Bacterial Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0016223

Déclaration de conflit d'intérêts

This study was performed by JMI Laboratories and supported by Melinta Therapeutics, which included funding for services related to preparing this manuscript.

Références

Antimicrob Agents Chemother. 2010 Jan;54(1):565-9
pubmed: 19884379
J Antimicrob Chemother. 1999 Apr;43(4):523-7
pubmed: 10350382
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28652234
Antimicrob Agents Chemother. 2000 Dec;44(12):3322-7
pubmed: 11083635
Clin Microbiol Rev. 2009 Jan;22(1):161-82, Table of Contents
pubmed: 19136439
Antimicrob Agents Chemother. 2006 May;50(5):1633-41
pubmed: 16641429
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Evol Bioinform Online. 2013;9:127-36
pubmed: 23531787
Clin Microbiol Rev. 2019 Aug 28;32(4):
pubmed: 31462403
Clin Infect Dis. 2019 Nov 13;69(Suppl 7):S565-S575
pubmed: 31724043
Antimicrob Agents Chemother. 2020 Jan 27;64(2):
pubmed: 31712207
Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0213021
pubmed: 36374023
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Pharmacotherapy. 2018 Apr;38(4):444-461
pubmed: 29427523
Antimicrob Agents Chemother. 2009 May;53(5):1766-71
pubmed: 19258272
Antimicrob Agents Chemother. 2011 May;55(5):1906-11
pubmed: 21357294
J Antimicrob Chemother. 2011 Sep;66(9):2022-7
pubmed: 21653605
J Antimicrob Chemother. 2014 Jul;69(7):1804-14
pubmed: 24603963
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500

Auteurs

Mariana Castanheira (M)

JMI Laboratories , North Liberty, Iowa, USA.

Timothy B Doyle (TB)

JMI Laboratories , North Liberty, Iowa, USA.

Cory M Hubler (CM)

JMI Laboratories , North Liberty, Iowa, USA.

Sean DeVries (S)

JMI Laboratories , North Liberty, Iowa, USA.

Dee Shortridge (D)

JMI Laboratories , North Liberty, Iowa, USA.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Classifications MeSH